Characterization and evaluation of bone-derived nanoparticles as a novel ph-responsive carrier for delivery of doxorubicin into breast cancer cells

Sheikh Tanzina Haque, Rowshan Ara Islam, Siew Hua Gan, Ezharul Hoque Chowdhury

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Background: The limitations of conventional treatment modalities in cancer, especially in breast cancer, facilitated the necessity for developing a safer drug delivery system (DDS). Inorganic nano-carriers based on calcium phosphates such as hydroxyapatite (HA) and carbonate apatite (CA) have gained attention due to their biocompatibility, reduced toxicity, and improved therapeutic efficacy. Methods: In this study, the potential of goose bone ash (GBA), a natural derivative of HA or CA, was exploited as a pH-responsive carrier to successfully deliver doxorubicin (DOX), an anthracycline drug into breast cancer cells (e.g., MCF-7 and MDA-MB-231 cells). GBA in either pristine form or in suspension was characterized in terms of size, morphology, functional groups, cellular internalization, cytotoxicity, pH-responsive drug (DOX) release, and protein corona analysis. Results: The pH-responsive drug release study demonstrated the prompt release of DOX from GBA through its disintegration in acidic pH (5.5–6.5), which mimics the pH of the endosomal and lysosomal compartments as well as the stability of GBA in physiological pH (pH 7.5). The result of DOX binding with GBA indicated an increment in binding affinity with increasing concentrations of DOX. Cell viability and cytotoxicity analysis showed no innate toxicity of GBA particles. Both qualitative and quantitative cellular uptake analysis in both cell lines displayed an enhanced cellular internalization of DOX-loaded GBA compared to free DOX molecules. The protein corona spontaneously formed on the surface of GBA particles exhibited its affinity toward transport proteins, structural proteins, and a few other selective proteins. The adsorption of transport proteins could extend the circulation half-life in biological environment and increase the accumulation of the drug-loaded NPs through the enhanced permeability and retention (EPR) effect at the tumor site. Conclusion: These findings highlight the potential of GBA as a DDS to successfully deliver therapeutics into breast cancer cells.

    Original languageEnglish
    Article number6721
    Number of pages26
    JournalInternational Journal of Molecular Sciences
    Volume21
    Issue number18
    DOIs
    Publication statusPublished - 14 Sep 2020

    Keywords

    • Breast cancer
    • Carbonate apatite (CA)
    • Carbonated apatite
    • Cellular uptake
    • Cytotoxicity
    • DOX binding
    • Goose bone ash (GBA)
    • Nano-carrier
    • PH responsive drug delivery
    • Protein corona

    Cite this